Please login to the form below

Not currently logged in

early access

This page shows the latest early access news and features for those working in and with pharma, biotech and healthcare.

Segmentation, evolved

Segmentation, evolved

a cluster of adaptations - from early market access involvement to re-engineered metrics - that I’ve observed in the evolution of various innovation-based life science business models. ... It’s too early to tell if it will work, but it looks promising

Latest news

More from news
Approximately 73 fully matching, plus 148 partially matching documents found.

Latest Intelligence

  • Rare diseases: meeting the challenge Rare diseases: meeting the challenge

    Ambitious strategy. “Companies need to set an ambitious strategy for pricing and market access early on, ”Barham continues. ... No system is perfect, ”Barham concludes. “But there is scope for improvements in all countries to try to reach a

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    Marketing authorisations. With no access to the single market, UK pharmaceutical companies will be forced to make two separate regulatory submissions - one to the EU and one to the UK. ... 4.The Early Access to Medicine Scheme (EAMS) could be adopted

  • Lighting the way Lighting the way

    current Patient Access Schemes that pharma companies agree with the Department of Health with input from NICE. ... Ultimately the government says the Review's recommendatiosn have the potential to cut four years from the process, through a funded Early

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The AM-VSG is expected to be enacted early in 2017. UK: faster access for innovative drugs, but challenges for other products. ... in the Early Access to Medicines Scheme (EAMS), streamlining health technology assessment and facilitating commissioning

  • An exciting outlook for pre-approval access and compassionate use An exciting outlook for pre-approval access and compassionate use

    Various projects across the industry are currently underway to establish fair and transparent mechanisms and recommendations on extremely difficult ethical decisions related to early access, including Janssen's independent review panel ... I am

More from intelligence
Approximately 5 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • TVF Communications shortlisted for the second year in a row for Writing Excellence award at Communique 2017

    A primary aim was to overcome the challenges associated with lack of early diagnosis, patient access, availability of treatment and patient stigma, which in partnership with AbbVie was made possible.

  • OPEN Access Consulting

    OPEN Access Consulting. OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. ... What OPEN Access Consulting do:. We have unrivalled experience in the delivery of market access programmes from early phase insights to

  • How can pharma help the NHS drive much-needed change in mental health services?

    The PoE programme aims to achieve this through prevention, early intervention, access to crisis care on a 24/7 basis and better integration of mental and physical healthcare. ... Changes that could help to achieve PoE. Early intervention is key and GPs

  • Accession

    The early industry pioneers of market access, are the creative force behind Accession. ... Today we are a specialist team of market access innovators, go-getters, strategists, scientists, analysts, and economists.

  • Determining value to withstand all tests

    The article in Pharmaceutical Marketing Europe discusses the need for functions to better join forces early in the access continuum in the interest of defining and delivering value that is going

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...